Ipsen Biopharm Limited

Royaume‑Uni


 
Quantité totale PI 269
Rang # Quantité totale PI 4 774
Note d'activité PI 3/5.0    160
Rang # Activité PI 4 290
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

74 13
32 26
61 27
36
 
Dernier brevet 2024 - Treatment of a headache disorder...
Premier brevet 2004 - Quantification of botulinum toxin
Dernière marque 2024 - DYSPORT DIRECT
Première marque 1989 - DYSPORT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmacy services; online retail store services featuring pharmaceutical products; online retail ...
P/S Research and development in the pharmaceutical and biotechnology fields; providing medical and sc...
Invention Methods for treating metastatic pancreatic cancer using combination therapies comprising liposoma...
Invention Treatment of a headache disorder with a botulinum neurotoxin a. The present invention is directed...
P/S Pharmaceutical preparations for the diagnosis and treatment of cancer for human use.
Invention Methods for treating pancreatic cancer using combination therapies. Provided are methods for tre...
Invention Methods for treating pancreatic cancer using combination therapies comprising liposomal irinoteca...
P/S Downloadable electronic publications, podcasts and videos in the field of botulinum toxin. Printe...
P/S Downloadable electronic publications in the nature of podcasts and audio files in the field of bo...
P/S Downloadable electronic publications, podcasts and videos in the field of botulinum toxin. Print...
P/S Downloadable electronic publications, podcasts and videos in the field of botulinum toxin. Printe...
2023 Invention Clostridial neurotoxin for use in a treatment of bladder pain syndrome. The present invention pro...
Invention Clostridial neurotoxins comprising an activating endosomal protease cleavage site. The present in...
Invention Clostridial neurotoxins comprising an activating exogenous protease cleavage site. The present in...
Invention Liquid neurotoxin formulation stabilized with tryptophan or tyrosine. The invention relates to s...
Invention Cell-free clostridial neurotoxin assays. The present invention is directed to cell-free methods, ...
P/S Downloadable electronic publications in the field of botulinum toxin. Printed matter, brochures, ...
P/S Downloadable electronic publications in the field of botulinum toxin. Printed matter, brochures,...
P/S Downloadable electronic publications in the field of botulinum toxin. Printed matter, brochures, ...
Invention Treatment of upper facial lines. NCC domain).
Invention Treatment of limb spasticity. The invention is directed to treatment of limb spasticity using a m...
Invention Treatment of cervical dystonia. The present invention is directed inter alia to a modified botuli...
Invention Bont/a for use in treating a facial dystonia. The present invention is directed to a modified bot...
Invention Non-neuronal snare-cleaving botulinum neurotoxins. The present invention provides a modified bot...
Invention Treatment of lower limb spasticity. A method of treating lower limb spasticity in a subject, par...
Invention Treatment of moderate to very severe glabellar lines and lateral canthal lines. Disclosed herein ...
2022 Invention Treatment of pain. The present invention is directed inter alia to the treatment of pain. For exa...
Invention Treatment of pain. NN domain), and a BoNT/B receptor binding domain (He domain). Also provided ar...
Invention Treatment of visceral pain. The present invention provides a clostridial neurotoxin for use in a ...
Invention Liposomes useful for drug delivery. The present invention provides liposome compositions contain...
Invention Modified bont/a for use in the treatment of a disorder affecting an eyelid muscle of a subject. T...
Invention Modified bont/a for use in the treatment of cervical dystonia. The present invention is directed ...
Invention Modified bont/a for use in the treatment of cervical dystonia. CC domain). Also provided are asso...
Invention Stabilizing camptothecin pharmaceutical compositions. Irinotecan phospholipid liposomes with imp...
Invention Chimeric neurotoxins. The present invention relates to chimeric neurotoxins with enhanced proper...
Invention Treatment of pain & inflammatory disorders. The present invention is directed to a polypeptide fo...
Invention Treatment of pain & inflammatory disorders. NCC domain), wherein when the polypeptide comprises a...
Invention Clostridial neurotoxins comprising an exogenous activation loop. The present invention relates t...
Invention Clostridial neurotoxins comprising an exogenous activation loop. The present invention relates to...
Invention Combination therapy for cancer treatment. Combination therapies for treating cancer comprising ad...
Invention Nanoliposomal irinotecan for use in treating small cell lung cancer. Novel therapies for the tre...
Invention Modified clostridial neurotoxins. The present invention is directed to a modified clostridial ne...
Invention Treatment of brain damage. The present invention provides a clostridial neurotoxin for use in a ...
2021 Invention Treatment of post-operative surgical pain. The present invention relates to a clostridial neurot...
P/S Injection syringes, disposable hypodermic syringes for medical use, syringes for medical purposes...
Invention Controlling operation of a bioreactor vessel. There is provided a method of controlling operatio...
P/S Cosmetic preparations for skin care. Pharmaceutical preparations. Injection device for pharmaceut...
P/S Educational services, namely, congresses and workshops in the fields of healthcare, disease diagn...
P/S Education and training services for healthcare professionals in the field of neurological disease...
P/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes...
Invention Catalytically inactive clostridial neurotoxins for the treatment of pain & inflammatory disorders...
Invention Treatment of upper facial lines. The present invention relates to a modified BoNT/A for use in t...
Invention Treatment of limb spasticity. The present invention relates to a modified botulinum neurotoxin A...
Invention Treatment of skin conditions. The present invention relates to the treatment of skin conditions ...
2020 P/S Arranging and conducting conferences, workshops and seminars in the field of botulinum toxin inje...
Invention Method of purifying botufinum toxin. The present technology relates to commercial-scale methods ...
Invention Method of producing botulinum toxin. The present disclosure relates generally to the field of pr...
P/S Clinical trials; Conducting clinical trials for pharmaceutical products; Providing medical and sc...
Invention Treatment of neurological disorders. The present invention is directed to a polypeptide for use ...
P/S Conducting clinical trials for pharmaceutical products; Research on the subject of pharmaceutical...
P/S Research and development in the pharmaceutical and biotechnology fields; provision of information...
P/S Research and development in the pharmaceutical field; research and development in the biotechnolo...
P/S Research and development in the pharmaceutical and biotechnology fields; provision of informatio...
2019 Invention Cell-based clostridal neurotoxin assays. The present invention is directed to a method for ident...
P/S Preparations for the treatment of frown lines and other wrinkles, in particular facial wrinkles; ...
2018 P/S Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroente...
P/S Pharmaceutical preparations. Conducting clinical trials for pharmaceutical products; Research on ...
2017 P/S Cosmetic preparations for skin care. Pharmaceutical preparations for the treatment of muscle dise...
2016 P/S Research and development in the pharmaceutical and biotechnology fields; providing medical and s...
P/S Cosmetic preparations for skin care. Pharmaceutical preparations, excluding contraceptive product...